10/02/2024
3:36 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:50 PM | Pannu Geraldine (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:51 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:47 PM | Baluch Khoso (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:48 PM | Neal James R (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:15 PM | Processa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
08/02/2024
4:28 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
4:31 PM | Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
4:34 PM | Bigora Sian (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
4:09 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
4:59 PM | Processa Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/18/2024
3:42 PM | Processa Pharmaceuticals (Issuer)
SKIBSTED RUSSELL (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
3:46 PM | Processa Pharmaceuticals (Issuer)
SKIBSTED RUSSELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
1:19 PM | Processa Pharmaceuticals (Filer)
| Form DEFR14A | |
05/28/2024
11:15 PM | Processa Pharmaceuticals (Filer)
| Form EFFECT | |
05/28/2024
3:49 PM | Processa Pharmaceuticals (Filer)
| Form 424B5 | |
05/21/2024
3:13 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:57 PM | Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:01 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:50 PM | Guy Wendy (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:52 PM | Bigora Sian (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:55 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
11:05 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
4:25 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
3:22 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
5:32 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:34 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:37 PM | Ng George K (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
9:46 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2024
11:15 PM | Processa Pharmaceuticals (Filer)
| Form EFFECT | |
01/25/2024
7:35 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
7:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
3:30 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
7:55 AM | Processa Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/19/2023
8:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
2025: Digital Asset Insights You Need to Know (Ad) Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto.
Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential. Get your guide today! |
12/05/2023
4:18 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free PCSA Stock Alerts